Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-73,225
Closed -$33.1K 4027
2025
Q2
$33.1K Buy
+73,225
New +$31.9K ﹤0.01% 3557
2023
Q3
Sell
-48,500
Closed -$35.4K 3047
2023
Q2
$35.4K Sell
48,500
-250
-0.5% -$232 ﹤0.01% 2470
2023
Q1
$36.9K Sell
48,750
-750
-2% -$697 ﹤0.01% 2375
2022
Q4
$47.6K Buy
49,500
+20,999
+74% +$29.7K ﹤0.01% 2238
2022
Q3
$62K Buy
28,501
+1
+0% +$3 ﹤0.01% 2102
2022
Q2
$100K Buy
28,500
+1,000
+4% +$3.74K ﹤0.01% 1974
2022
Q1
$139K Buy
27,500
+5,700
+26% +$28.9K ﹤0.01% 1949
2021
Q4
$137K Buy
21,800
+10,391
+91% +$71K ﹤0.01% 1926
2021
Q3
$91K Buy
+11,409
New +$93.9K ﹤0.01% 1953
2021
Q1
Sell
-11,100
Closed -$63K 2736
2020
Q4
$63K Sell
11,100
-2,440
-18% -$15.5K ﹤0.01% 2081
2020
Q3
$90K Buy
+13,540
New +$121K ﹤0.01% 1840
2017
Q3
Sell
-8
Closed 3690
2017
Q2
$0 Hold
8
﹤0.01% 4849
2017
Q1
$0 Hold
8
﹤0.01% 4925
2016
Q4
$0 Sell
8
-1
-11% -$15 ﹤0.01% 4859
2016
Q3
$0 Sell
9
-180
-95% -$2.85K ﹤0.01% 4749
2016
Q2
$3K Hold
189
﹤0.01% 3918
2016
Q1
$3K Hold
189
﹤0.01% 3842
2015
Q4
$4K Buy
+189
New +$4.15K ﹤0.01% 3812
2015
Q2
Sell
-2
Closed 2999
2015
Q1
$0 Buy
+2
New +$55 ﹤0.01% 4430

Other funds holding VXRT

Creative Planning's VXRT Position: Q3 2025 in Review

Creative Planning sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 73,225 shares — an estimated $33.1K sold.

Creative Planning first reported a position in VXRT in Q1 2015 and held it in 19 quarters. The position peaked at $139K in Q1 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Creative Planning reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Creative Planning sold 73,225 Vaxart shares in Q3 2025, an estimated $33.1K.
  • Creative Planning first reported a position in Vaxart in Q1 2015 and held it in 19 quarters.
  • Creative Planning's Vaxart position peaked at $139K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.